Translational Lung Cancer Research

Article	Citations
Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial	96
Tackling the challenge of brain involvement in driver-negative non-small cell lung cancer	96
Towards a clinically applicable histomolecular classification of lung adenocarcinomas?	56
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel	53
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy	48
Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients	48
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer	46
Contribution of crosstalk of mesothelial and tumoral epithelial cells in pleural metastasis of lung cancer	43
Contrast-enhanced CT and PET-CT characteristics of primary tracheal lymphoepithelioma-like carcinoma: case series	42
Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung	41
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-cent	39
Alectinib continuation beyond progression in ALK-positive non-small cell lung cancer with alectinib-refractory	38
Osimertinib as induction therapy for oligometastatic non-small cell lung cancer with EGFR mutation: a case report	37
Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302)	36
Molecular biomarkers in early stage lung cancer	33
Supervision by an experienced surgeon can reduce the learning curve of uniportal thoracoscopic lobectomy	33
Limited-anatomic resection for ground-glass like lung cancer—simplicity does not mean inefficacy	32
The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer	32
Cost-effectiveness analysis of anlotinib as a third-line or further treatment for advanced non-small cell lung cancer in China	32
Circulating mitochondrial DNA as a biomarker for lung cancer screening	31
Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer	29
Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system	28
Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?	28
Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition	28
Surgical perception of lower tracheal or carinal resection	27

Pushing the boundaries of minimally invasive surgery	26
One more piece to SOLIDify our knowledge on the impact of SARS-CoV-2 in patients with cancer	25
Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist	25
Utility and safety of sole electromagnetic navigation bronchoscopy under moderate sedation for lung cancer diagnosis	25
CLOCK’ing differences in DNA methylation signatures to understand the molecular etiology of lung cancer	25
Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer	25
Pathological and imaging features of pulmonary invasive mucinous adenocarcinoma—a retrospective cohort study	24
Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer	24
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma	23
Has programmed cell death ligand-1 MET an accomplice in non-small cell lung cancer?—a narrative review	23
Carinal resection and reconstruction with complete pulmonary parenchyma preservation: a single-institution analysis of 36 cases	23
HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma	23
The clinico-pathological characteristics of surgically treated young women with NSCLC	22
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a	22
Efficacy and safety of alectinib in ALK-positive non-small cell lung cancer and blood markers for prognosis and efficacy: a retrospective cohort study	22
Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review	21
Surgical mediastinal lymph node staging for non-small-cell lung carcinoma	21
Lobectomy with pulmonary artery angioplasty for lung cancer using video-assisted thoracic surgery versus open thoracotomy: a retrospective propensity matched analysis	21
Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon?	20
Increased detection of circulating tumor DNA by short fragment enrichment	20
PFKP confers chemoresistance by upregulating ABCC2 transporter in non-small cell lung cancer	20
A random forest algorithm predicting model combining intraoperative frozen section analysis and clinical features guides surgical strategy for peripheral solitary pulmonary nodules	20
Editorial on implementation of CT-based screening of lung cancer	19
PD-L1 expression in non-small cell lung carcinoma in Latin America: a systematic review and meta-analysis	19
Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer	19
The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target—a narrative review	19
Efficacy of alectinib in lung adenocarcinoma patients with different anaplastic lymphoma kinase (ALK) rearrangements and co-existing alterations—a retrospective cohort study	19
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study	19
The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016–2030	18
Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review	18
Prediction of future imagery of lung nodule as growth modeling with follow-up computed tomography scans using deep learning: a retrospective cohort study	18
A narrative review of deep learning applications in lung cancer research: from screening to prognostication	18
Added benefits of early detection of other diseases on low-dose CT screening	18
Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma	18
A multi-level investigation of the genetic relationship between gastroesophageal reflux disease and lung cancer	17
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma	17
Pembrolizumab plus platinum-based chemotherapy for squamous non-small cell lung cancer: the new kid on the block	17
Tremelimumab and durvalumab with chemotherapy in first-line treatment for metastatic non-small cell lung cancer: a US-based cost-effectiveness analysis	17
Comparison of perioperative outcomes among non-small cell lung cancer patients with neoadjuvant immune checkpoint inhibitor plus chemotherapy, EGFR-TKI, and chemotherapy alone: a real-world evidence s	17
Squamous-cell carcinoma of the recipient’s explanted lung	17
Impact of chronic obstructive pulmonary disease on lung cancer symptom burden: a population-based study in Ontario, Canada	16
Adjuvant treatment for patients with incidentally resected limited disease small cell lung cancer—a retrospective study	16
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study	16
Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-bas	16
“We need to work towards it, whatever it takes.”—participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders	16
Pathological and radiological T descriptors in invasive lung adenocarcinoma: from correlations to prognostic significance	16
Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network	16
Tract creation with a 25-gauge needle for convex endobronchial ultrasound-guided core biopsy in intrapulmonary lesions adjacent to bronchi: three case reports	15
Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review	15
Predictive biomarkers for immune checkpoint efficacy: is multi-omics breaking the deadlock?	15

Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment	15
Electromagnetic navigation bronchoscopy-guided preoperative lung nodule localization in video-assisted thoracic surgery (VATS): a learning curve analysis	15
Exposure-lag response of surface net solar radiation on lung cancer incidence: a global time-series analysis	15
End-to-side anastomosis in complex tracheal resection and reconstruction: a case series study	15
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients	15
A nomogram for predicting invasiveness of lung adenocarcinoma manifesting as ground-glass nodules based on follow-up CT imaging	15
Prognostic implications of cellular senescence in resected non-small cell lung cancer	14
Patient-led advocacy in ALK-positive lung cancer	14
The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential b	14
MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report	14
Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot study	14
Metastatic pulmonary carcinoids with EML4-ALK fusion response to ALK inhibitors: two case reports and review of literature	14
Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors	14
Circ_0087378 intensifies the malignant behavior of non-small cell lung cancer cells in vitro by facilitating DDR1 via sponging miR-199a-5p	14
Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier	14
Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort stud	14
Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure	14
Dielectric property measurements for the rapid differentiation of thoracic lymph nodes using XGBoost in patients with non-small cell lung cancer: a self-control clinical trial	14
Cathepsin detection to identify malignant cells during robotic pulmonary resection	14
Navigation of video-assisted thoracoscopic surgery using electromagnetic versus CT-guided localization (NOVEL): a study protocol for comparing procedural success and complication rates in a prospectiv	14
Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer	14
A large-scale, multicentered trial evaluating the sensitivity and specificity of digital PCR versus ARMS-PCR for detecting ctDNA-based EGFR p.T790M in non-small-cell lung cancer patients	13
Perioperative and long-term outcomes of spontaneous ventilation video-assisted thoracoscopic surgery for non-small cell lung cancer	13
Steerable guiding sheaths in peripheral bronchoscopy	13
Combinatorial therapy is a safe and durable treatment option in ALK-rearranged non-small cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report	13
The incidence and risk factors of acute pain after preoperative needle localization of pulmonary nodules: a cross-sectional study	13
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy	13
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis	13
Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?	13
Risk-based prediction model for selecting eligible population for lung cancer screening among ever smokers in Korea	13
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients	13
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer	13
Prognostic value of L4 lymph node dissection during video-assisted thoracoscopic surgery in patients with left-sided non-small cell lung cancer: a single-center, retrospective cohort study	13
A pilot study of anlotinib with third-generation epidermal growth factor receptor tyrosine kinase inhibitors in untreated EGFR-mutant patients with advanced non-small cell lung cancer	12
Effect of family history of cancer on postoperative survival in patients with non-small cell lung cancer	12
The (un)lucky seven—how can we mitigate risk factors for postoperative pneumonia after lung resections?	12
PTS is activated by ATF4 and promotes lung adenocarcinoma development via the Wnt pathway	12
Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry	12
The current state of carinal resection and role of minimally invasive techniques	12
Clinical and financial impact of immune checkpoint inhibitors following platinum chemotherapy in patients with advanced or metastatic non-small cell lung cancer: a nationwide population-based study	12
Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients	12
The person behind the nodule: a narrative review of the psychological impact of lung cancer screening	12
Clinical insights: five-year follow-up of KEYNOTE-189 trial outcomes and more	12
Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer—a narrative review	12
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature	12
Effect of prior therapy on tumor mutational burden in NSCLC	12
Real-time digital polymerase chain reaction (PCR) as a novel technology improves limit of detection for rare allele assays	12
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report	12
Adrenal crisis and acute exacerbation of interstitial lung disease after thymoma needle biopsy: a case report and literature review	12
Can a dysfunctional T-cell gene signature predict nonresponse to PD-1 blockade in non-small cell lung cancer?	12
CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer	12
Macrophages-based immune-related risk score model for relapse prediction in stage I–III non-small cell lung cancer assessed by multiplex immunofluorescence	12
Comparison of lobectomy performed through Toumai® surgical robot and da Vinci surgical robot in early-stage non-small cell lung cancer: a retrospective study of early perioperative results	12
PD-L1 expression from surgically resected lung tumors predictive of early progression in patients previously treated with targeted therapy for initially unresectable non-small cell lung cancer	12
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review	12
Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer	12
EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature	12
Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review	11
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1–N2 epidermal growth factor receptor mutant lung adenocarcinoma	11
Long-term survival after combination therapy with atezolizumab in a patient with small-cell lung cancer: a case report	11
Enhancing the prediction of KRAS mutation status in Asian lung adenocarcinoma: a comprehensive approach combining clinical, dual-energy spectral computed tomography, and radiomics features	11
Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer	11
Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinoma	11
Integrated analysis reveals the microenvironment of non-small cell lung cancer and a macrophage-related prognostic model	11
Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer	11
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma	11
Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives	11
Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer	11
A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer	11
Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis	11
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes	11
Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab	11
Prognostic value of ground-glass opacity on computed tomography for patients with pathological stage IA3 lung adenocarcinoma: a multicenter retrospective cohort study	11
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistanc	11
Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients wit	11
Augmented reality-assisted localization of solitary pulmonary nodules for precise sublobar lung resection: a preliminary study using an animal model	11
Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target	11
Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma	11
Menstrual factors, reproductive history, and risk of lung cancer: a multi-center population-based cohort study in Chinese females	11
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question	11

Construction of a neutrophil extracellular trap formation-related gene model for predicting the survival of lung adenocarcinoma patients and their response to immunotherapy	11
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients	11
Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer	11
Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study	11
The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases	11
TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis	11
Dose and fractionation schedules in radiotherapy for non-small cell lung cancer	11
Fuel for thought: targeting metabolism in lung cancer	10
Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study	10
Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea	10
A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma	10
Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer	10
Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021	10
Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report	10
Emerging and multifaceted role of neutrophils in lung cancer	10
Adjuvant chemotherapy for completely resected IIA–IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice	10
Application of indocyanine green injection guided by electromagnetic navigation bronchoscopy in localization of pulmonary nodules	10
Successful long-term outcome of neoadjuvant sequential targeted therapy and chemotherapy for stage III non-small cell lung carcinoma: 10 case series	10
How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review	10
Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma	10
GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer	10
KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component	9
Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy	9
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer	9
High NHLRC2 expression is associated with shortened survival in lung adenocarcinoma	9
The clinical characteristics, treatments and prognosis of post-esophagectomy airway fistula: a multicenter cohort study	9
ATM—the gene at the moment in non-small cell lung cancer	9
TTF-1 and immune checkpoint therapy in non-small cell lung cancer	9
Robot-assisted minimally invasive bronchial resection with primary anastomosis for schwannoma arising from left main bronchus: a case report	9
Immunotherapy: remember the host	9
Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report	9
Latest CT technologies in lung cancer screening: protocols and radiation dose reduction	9
Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer	9
Lung autotransplantation for advanced central lung cancer after neoadjuvant immuno-chemotherapy: a case series study	9
Patterns and outcome of unplanned care in lung cancer patients: an observational study in a medical oncology department	9
A simple and safe surgical technique for nonpalpable lung tumors: One-stop Solution for a nonpalpable lung tumor, Marking, Resection, and Confirmation of the surgical margin in a Hybrid operating room	9
A cross-trait study of lung cancer and its related respiratory diseases based on large-scale exome sequencing population	9
PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer	9
The role of laboratory tests as a prognostic marker for immune-checkpoint therapy in non-small cell lung cancer	9
Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1	9
EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates	9
Does subtyping of high-grade pulmonary neuroendocrine carcinomas have an impact on therapy selection?	9
KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer	9
Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1	9
Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer	9
The role of RASA2 in predicting radioresistance in lung cancer through regulation of p53	9
Molecular mechanism and clinical outcome of non-small cell lung cancer patients with high BRAF expression	8
Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to predict early response to anti-tumor therapy in advanced non-small cell lung cancer (NSCLC): a comparison of intravoxel incoherent moti	8
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer	8
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open- label phase 2 study (CLEAR)	8
Therapy option for early-stage lung cancer in nonsurgical patients	8
A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy	8
Tarlatamab: the promising immunotherapy on its way from the lab to the clinic	8
Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database	8
The strategy of non-intubated spontaneous ventilation anesthesia for upper tracheal surgery: a retrospective case series study	8
The predictive accuracy of CT radiomics combined with machine learning in predicting the invasiveness of small nodular lung adenocarcinoma	8
Advancements of ALK inhibition of non-small cell lung cancer: a literature review	8
The opportunities and challenges of perioperative therapy of localized non-small cell lung cancer—thoughts from the KEYNOTE-671 trial	8
International consensus on severe lung cancer—the first edition	8
NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma	8
Bronchoscopic deployment and implantation of Diffusing alpha-emitters Radiation Therapy into the lung and mediastinum for treatment of lung cancer: a pre-clinical safety and feasibility study	8
Differences in detection patterns, characteristics, and outcomes of central and peripheral lung cancers in low-dose computed tomography screening	8
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments	8
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk	8
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?	8
Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration	8
Heterogeneity of lymphocyte subsets in predicting immune checkpoint inhibitor treatment response in advanced lung cancer: an analysis across different pathological types, therapeutic drugs, and age gr	8
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?	8
Re-evaluating the need for mediastinal lymph node dissection and exploring lncRNAs as biomarkers of N2 metastasis in T1 lung adenocarcinoma	8
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas	8
Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report	8
Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?	8
Feasibility and safety of pedicled autologous bronchial flap reconstruction airway instead of sleeve lobectomy in partial lung cancer surgery	8
Immunotherapy in oncogene addicted non-small cell lung cancer	8
Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence	8
Hyperprogression under immunotherapy: a new form of immunotherapy response?—a narrative literature review	8
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts	8
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAFV600E mutation: a multi-center real-world experience in China	8
Screen-detected solid nodules: from detection of nodule to structured reporting	8
Prophylactic cranial irradiation in SCLC	7
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors	7
Establishment and validation of a nomogram model for predicting postoperative recurrence-free survival in stage IA3 lung adenocarcinoma: a retrospective cohort study	7
Immunotherapy for non-small cell lung cancer with EGFR or HER2 exon 20 insertion mutations: a real-world analysis	7
Outcomes of initial therapy for synchronous brain metastases from small cell lung cancer: a single-institution retrospective analysis	7
Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma	7
Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited	7
Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor	7
Extended lobectomy—how minimally invasive can we go?	7
Development and verification of new monoclonal orthopedia homeobox (OTP) specific antibodies for pulmonary carcinoid diagnostics	7
HSP90 expression is associated with outcome in pulmonary carcinoid tumor patients	7
Orthopedia homeobox protein (OTP) in the diagnostic and prognostic workup of pulmonary carcinoid tumors	7
The miR-4306/IGF2R axis modulates the lung adenocarcinoma response to irradiation in vitro and in vivo	7
Prominent response to savolitinib monotherapy in high-grade fetal adenocarcinoma with MET amplification and concurrent brain metastasis: a case report	7
Unravelling the puzzle of immunotherapeutic efficacy in lung cancer	7
Prognosis of pulmonary lymphangitic carcinomatosis in patients with non-small cell lung cancer	7